红藤汤灌肠治疗慢性盆腔炎临床观察

Clinical Observation on Hongteng Decoction Enema in the Treatment of Chronic Pelvic Inflammatory Disease

目的探讨红藤汤灌肠治疗慢性盆腔炎的临床疗效。方法选取2017年1月—2018年1月收治的慢性盆腔炎患者74例,分为2组,各37例。给予常规组患者莫西沙星治疗,给予试验组患者莫西沙星联合红藤汤灌肠治疗。对比2组患者不同治疗后临床疗效的差异性。结果试验组白细胞水平值为(5.24±3.01)×10^9/L、降钙素原水平值为(11.08±3.14)ng/L、C反应蛋白CRP水平值为(4.09±1.24)mg/L,白细胞介素6水平值为(129.11±22.14)ng/L,均明显低于常规组(P<0.05);试验组治疗总有效率为94.59%,明显高于常规组(P<0.05)。结论相比单用莫西沙星治疗,红藤汤灌肠治疗慢性盆腔炎的临床疗效更加显著,可推广应用。

Objective To investigate the clinical effect of Hongteng decoction enema in the treatment of chronic pelvic inflammatory disease. Methods From January 2017 to January 2018, 74 patients with chronic pelvic inflammatory disease admitted to our hospital were selected as the study subjects. 37 patients in the conventional group were treated with moxifloxacin, and 37 patients in the experimental group were treated with moxifloxacin combined with Hongteng decoction enema. The clinical efficacy of the two groups was compared after different treatments. Results The levels of leucocyte (5.24±3.01)×10^9/L, procalcitonin (11.08±3.14) ng/L, CRP (4.09±1.24) mg/L and interleukin-6 (129.11±22.14) ng/L in the experimental group were significantly lower than those in the conventional group (P<0.05). The total effective rate of the experimental group was 94.59%, which was significantly higher than that of the conventional group (P<0.05). Conclusion Compared with moxifloxacin alone, Hongteng decoction enema has more significant clinical efficacy in the treatment of chronic pelvic inflammatory disease, which can be widely used.